Human Endogenous Retrovirus K Gag Coassembles with HIV-1 Gag and Reduces the Release Efficiency and Infectivity of HIV-1

ABSTRACT Human endogenous retroviruses (HERVs), which are remnants of ancestral retroviruses integrated into the human genome, are defective in viral replication. Because activation of HERV-K and coexpression of this virus with HIV-1 have been observed during HIV-1 infection, it is conceivable that HERV-K could affect HIV-1 replication, either by competition or by cooperation, in cells expressing both viruses. In this study, we found that the release efficiency of HIV-1 Gag was 3-fold reduced upon overexpression of HERV-KCON Gag. In addition, we observed that in cells expressing Gag proteins of both viruses, HERV-KCON Gag colocalized with HIV-1 Gag at the plasma membrane. Furthermore, HERV-KCON Gag was found to coassemble with HIV-1 Gag, as demonstrated by (i) processing of HERV-KCON Gag by HIV-1 protease in virions, (ii) coimmunoprecipitation of virion-associated HERV-KCON Gag with HIV-1 Gag, and (iii) rescue of a late-domain-defective HERV-KCON Gag by wild-type (WT) HIV-1 Gag. Myristylation-deficient HERV-KCON Gag localized to nuclei, suggesting cryptic nuclear trafficking of HERV-K Gag. Notably, unlike WT HERV-KCON Gag, HIV-1 Gag failed to rescue myristylation-deficient HERV-KCON Gag to the plasma membrane. Efficient colocalization and coassembly of HIV-1 Gag and HERV-K Gag also required nucleocapsid (NC). These results provide evidence that HIV-1 Gag heteromultimerizes with HERV-K Gag at the plasma membrane, presumably through NC-RNA interaction. Intriguingly, HERV-K Gag overexpression reduced not only HIV-1 release efficiency but also HIV-1 infectivity in a myristylation- and NC-dependent manner. Altogether, these results indicate that Gag proteins of endogenous retroviruses can coassemble with HIV-1 Gag and modulate the late phase of HIV-1 replication.

[1]  P. Bieniasz,et al.  Reconstitution of an Infectious Human Endogenous Retrovirus , 2007, PLoS pathogens.

[2]  N. Bannert,et al.  Molecular cloning and functional characterization of the human endogenous retrovirus K113. , 2008, Virology.

[3]  R. Kurth,et al.  Structural organization of unique retrovirus-like particles budding from human teratocarcinoma cell lines. , 1983, The Journal of general virology.

[4]  Vincent Moulton,et al.  Mosaic Genomes of the Six Major Primate Lentivirus Lineages Revealed by Phylogenetic Analyses , 2003, Journal of Virology.

[5]  Rafael Contreras-Galindo,et al.  HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. , 2007, AIDS research and human retroviruses.

[6]  E. Freed,et al.  Binding of Human Immunodeficiency Virus Type 1 Gag to Membrane: Role of the Matrix Amino Terminus , 1999, Journal of Virology.

[7]  K. Kidd,et al.  Insertional polymorphisms of full-length endogenous retroviruses in humans , 2001, Current Biology.

[8]  P. Bieniasz,et al.  Analysis of the Initiating Events in HIV-1 Particle Assembly and Genome Packaging , 2010, PLoS pathogens.

[9]  D. Mccormick Sequence the Human Genome , 1986, Bio/Technology.

[10]  D. Pérez-Caballero,et al.  Context-Dependent Effects of L Domains and Ubiquitination on Viral Budding , 2004, Journal of Virology.

[11]  A. Hoppe,et al.  Quantitative Fluorescence Resonance Energy Transfer Microscopy Analysis of the Human Immunodeficiency Virus Type 1 Gag-Gag Interaction: Relative Contributions of the CA and NC Domains and Membrane Binding , 2009, Journal of Virology.

[12]  Chong-Hwan Chang,et al.  Inhibition of Human Endogenous Retrovirus-K10 Protease in Cell-free and Cell-based Assays* , 2001, Journal of Biological Chemistry.

[13]  R. Soeiro,et al.  Host restriction of Friend leukemia virus: synthesis and integration of the provirus. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Goff,et al.  Sequence and spacing requirements of a retrovirus integration site. , 1988, Journal of molecular biology.

[15]  Rafael Contreras-Galindo,et al.  Short Communication: Comparative Longitudinal Studies of HERV-K and HIV-1 RNA Titers in HIV-1-Infected Patients Receiving Successful versus Unsuccessful Highly Active Antiretroviral Therapy , 2007 .

[16]  N. Bannert,et al.  Retroelements and the human genome: New perspectives on an old relation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Francis Harper,et al.  Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. , 2006, Genome research.

[18]  Timothy B. Stockwell,et al.  The Sequence of the Human Genome , 2001, Science.

[19]  Marc C. Johnson,et al.  The Retroviral Capsid Domain Dictates Virion Size, Morphology, and Coassembly of Gag into Virus-Like Particles , 2005, Journal of Virology.

[20]  M. Dierich,et al.  Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K. , 1993, AIDS research and human retroviruses.

[21]  E. Freed,et al.  p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease , 1995, Journal of virology.

[22]  Mark H. Kaplan,et al.  Characterization of Human Endogenous Retroviral Elements in the Blood of HIV-1-Infected Individuals , 2011, Journal of Virology.

[23]  J. Coffin,et al.  Effects of retroviruses on host genome function. , 2008, Annual review of genetics.

[24]  Lisa Z. Scheifele,et al.  Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Jeffrey N. Martin,et al.  Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection , 2011, Journal of Virology.

[26]  S. Tsui,et al.  Detection and identification of plasma bacterial and viral elements in HIV/AIDS patients in comparison to healthy adults. , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  D. Baltimore,et al.  Effect of Fv-1 gene product on proviral DNA formation and integration in cells infected with murine leukemia viruses. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Naumann,et al.  Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element , 2011, Retrovirology.

[29]  International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome , 2001, Nature.

[30]  R. Kurth,et al.  The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Rafael Contreras-Galindo,et al.  A new Real-Time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. , 2006, Journal of virological methods.

[32]  Wesley I. Sundquist,et al.  Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding , 2001, Cell.

[33]  E. Arts,et al.  The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates , 2005, Journal of Virology.

[34]  K. Nagashima,et al.  Elimination of Protease Activity Restores Efficient Virion Production to a Human Immunodeficiency Virus Type 1 Nucleocapsid Deletion Mutant , 2003, Journal of Virology.

[35]  M. Swanson,et al.  Expression of Human Endogenous Retrovirus Type K (HML-2) Is Activated by the Tat Protein of HIV-1 , 2012, Journal of Virology.

[36]  R. Montelaro,et al.  Functional Replacement and Positional Dependence of Homologous and Heterologous L Domains in Equine Infectious Anemia Virus Replication , 2002, Journal of Virology.

[37]  G. Gottlieb,et al.  Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa. , 2003, AIDS research and human retroviruses.

[38]  Rafael Contreras-Galindo,et al.  Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. , 2007, AIDS research and human retroviruses.

[39]  Gregory Lefebvre,et al.  Analysis of HIV-1 Expression Level and Sense of Transcription by High-Throughput Sequencing of the Infected Cell , 2011, Journal of Virology.

[40]  Naveed Anwar,et al.  T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection , 2007, PLoS pathogens.

[41]  J. Wills,et al.  Conditions for Copackaging Rous Sarcoma Virus and Murine Leukemia Virus Gag Proteins during Retroviral Budding , 1999, Journal of Virology.

[42]  M. Jesudason,et al.  HIV-2 subtype circulating in India (south). , 2003, Journal of acquired immune deficiency syndromes.

[43]  J. Sodroski,et al.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[44]  J. Wills,et al.  Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins , 1995, Journal of virology.

[45]  J. Corbeil,et al.  A new reporter cell line to monitor HIV infection and drug susceptibility in vitro. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Kurth,et al.  Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. , 2008, The Journal of general virology.

[47]  Wei-Shau Hu,et al.  Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins. , 2007, Virology.

[48]  P. Earl,et al.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity , 1988, Journal of virology.

[49]  E. Freed,et al.  Association of Human Immunodeficiency Virus Type 1 Gag with Membrane Does Not Require Highly Basic Sequences in the Nucleocapsid: Use of a Novel Gag Multimerization Assay , 2005, Journal of Virology.

[50]  B. Schnierle,et al.  Characterization of the human endogenous retrovirus K Gag protein: identification of protease cleavage sites , 2011, Retrovirology.

[51]  D. Markovitz,et al.  Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. , 2006, AIDS research and human retroviruses.

[52]  E. Freed,et al.  New insights into HIV assembly and trafficking. , 2011, Physiology.

[53]  J. Lenz,et al.  A Single Amino Acid Substitution in a Segment of the CA Protein within Gag That Has Similarity to Human Immunodeficiency Virus Type 1 Blocks Infectivity of a Human Endogenous Retrovirus K Provirus in the Human Genome , 2008, Journal of Virology.

[54]  Martine Peeters,et al.  Hybrid Origin of SIV in Chimpanzees , 2003, Science.

[55]  D. Nixon,et al.  Identification of Human Endogenous Retrovirus-Specific T Cell Responses in Vertically HIV-1-Infected Subjects , 2011, Journal of Virology.

[56]  K. Nagashima,et al.  Coassembly and complementation of Gag proteins from HIV-1 and HIV-2, two distinct human pathogens. , 2006, Molecular cell.

[57]  Jianbo Chen,et al.  Capsid Proteins from Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus SIVmac Can Coassemble into Mature Cores of Infectious Viruses , 2008, Journal of Virology.